Lilly: Effective TB Care Starts with Early Diagnosis

Primary tabs

Lilly: Effective TB Care Starts with Early Diagnosis

By David Marbaugh
tweet me:
Programs like @UNITAID's #expandtb are crucial for closing the gap in undiagnosed #TB cases http://bit.ly/1phuRDU

Multimedia from this Release

Eli LIlly and Company's Dr. Evan Lee

Lilly MDR-TB Program

Friday, March 28, 2014 - 10:05am

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

Today's guest blog comes from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.

The World Health Organization reported some promising news this week: confirmed diagnoses of multidrug-resistant TB (MDR-TB) cases more than tripled between 2009 and 2013 in 27 countries targeted through an innovative collaboration called EXPAND-TB.

Why is this a good thing? Because diagnosis is the critical first step in treating and caring for people affected by MDR-TB. It is also important for their families and friends, who are at risk and other close contacts in the community. Yet most cases are missed – in 2012, less than a quarter of the 450,000 people estimated to have fallen ill with MDR-TB were diagnosed and officially notified to ministries of health.

Through initiatives like EXPAND-TB, we are starting to close that gap.

To learn more about developments in early TB detection, please read our blog.

Keywords: Health & Healthcare | Corporate Responsibility | Eli Lilly | Health & Healthcare | Lilly | MDR-TB | multidrug-resistant tuberculosis | tuberculosis

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

parse.ly